Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.390
+0.010 (0.72%)
At close: Mar 9, 2026, 4:00 PM EDT
1.390
0.00 (0.00%)
After-hours: Mar 9, 2026, 7:17 PM EDT
PACB Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -546.38 | -309.85 | -306.74 | -314.25 | -181.22 | |
| Depreciation & Amortization | 386.41 | 53.35 | 26.53 | 17.32 | 11.59 | |
| Asset Writedown & Restructuring Costs | 15 | 184.5 | - | - | - | |
| Loss (Gain) From Sale of Investments | -4.37 | -13.04 | -12.84 | -0.24 | 4.01 | |
| Stock-Based Compensation | 41.67 | 71.04 | 72.12 | 78.61 | 73.36 | |
| Other Operating Activities | -7.99 | -151.47 | 20.71 | 9.32 | -39.24 | |
| Change in Accounts Receivable | -7.92 | 9.09 | -17.83 | 5.46 | -7.17 | |
| Change in Inventory | -1.42 | -8.32 | -13.84 | -33.91 | -13.11 | |
| Change in Accounts Payable | 2.48 | 1.41 | 0.21 | 1.03 | 6.36 | |
| Change in Unearned Revenue | 0.1 | -2.11 | -10.42 | -3.73 | 25.74 | |
| Change in Other Net Operating Assets | 11.2 | -40.65 | -17.07 | -22.81 | 8.5 | |
| Operating Cash Flow | -111.21 | -206.06 | -259.17 | -263.21 | -111.18 | |
| Capital Expenditures | -2.71 | -6.19 | -8.84 | -16.75 | -5.93 | |
| Cash Acquisitions | - | - | -0.1 | - | -319.79 | |
| Sale (Purchase) of Intangibles | -5 | - | - | -0.18 | - | |
| Investment in Securities | 123.16 | 130.19 | 13.55 | 133.01 | -352.81 | |
| Investing Cash Flow | 115.45 | 124 | 4.6 | 116.08 | -678.53 | |
| Long-Term Debt Issued | - | - | - | - | 895.54 | |
| Long-Term Debt Repaid | - | -50.69 | -1.84 | -1.61 | -0.36 | |
| Net Debt Issued (Repaid) | - | -50.69 | -1.84 | -1.61 | 895.18 | |
| Issuance of Common Stock | 3.43 | 7.7 | 204.52 | 11.23 | 326.65 | |
| Other Financing Activities | - | - | -93.79 | - | -52.25 | |
| Financing Cash Flow | 3.43 | -42.99 | 108.89 | 9.62 | 1,170 | |
| Net Cash Flow | 7.67 | -125.04 | -145.68 | -137.51 | 379.87 | |
| Free Cash Flow | -113.92 | -212.25 | -268.02 | -279.96 | -117.11 | |
| Free Cash Flow Margin | -71.20% | -137.81% | -133.66% | -218.20% | -89.73% | |
| Free Cash Flow Per Share | -0.38 | -0.77 | -1.06 | -1.25 | -0.57 | |
| Cash Interest Paid | 8.26 | 14.81 | 15.69 | 14.05 | 6.93 | |
| Levered Free Cash Flow | 97.55 | -95.64 | -311.67 | 46.5 | -24.54 | |
| Unlevered Free Cash Flow | 101.89 | -87.26 | -302.7 | 55.68 | -16.71 | |
| Change in Working Capital | 4.44 | -40.58 | -58.96 | -53.97 | 20.33 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.